Peptide Histidine Isoleucine (PHI) in the Respiratory Tract
Peptide Histidine Isoleucine (PHI) in the Respiratory Tract
批准号:
02670336
负责人:
KUROSAWA Motohiro
金额:
$0.51万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992
中文摘要
(1)从大鼠PHI免疫家兔获得了与血管活性肠肽(VIP)不发生反应的高效价肽组氨酸异亮氨酸(PHI)抗血清,并用该抗血清建立了大鼠PHI放射免疫测定方法。采用微波辐照处死大鼠,解剖气管、肺外支气管和肺。用0.5 N醋酸匀浆,离心。冻干上清用作放射免疫测定的样品。PHI的免疫反应性主要发生在中央气道而非外周气道。大鼠呼吸道中VIP的免疫反应性与PHI的免疫反应性一样强,表明在大鼠呼吸道中,PHI和VIP可能是由同一前体以1:1的比例产生的。(2)静脉给药VIP或PHI可降低动态呼吸阻力;但效果明显低于异丙肾上腺素。VIP和P . More HI通过静脉给药组胺抑制动态呼吸阻力的增加,且呈剂量依赖性,提示VIP和PHI可能通过抑制介质释放对气道的影响参与气道高反应性的发病机制。(3) VIP对活化的外周血中性粒细胞、单核细胞和人单核细胞U937的超氧阴离子产生有剂量依赖性的抑制作用,其超氧阴离子的形成能力是通过干扰素γ预处理诱导的。VIP还能抑制支气管肺泡灌洗获得的活化的外周血嗜酸性粒细胞和肺泡巨噬细胞产生超氧阴离子,提示VIP可能是呼吸道炎症反应的内源性调节剂。(4)用大鼠PHI免疫家兔获得与VIP不发生反应的高效价PHI抗血清,用放射免疫法测定豚鼠呼吸道PHI样免疫反应性。对气管、肺外支气管和肺进行解剖,微波照射治疗。用0.5 N醋酸匀浆,离心。冻干上清用作放射免疫测定的样品。中心气道的PHI样免疫反应性高于外周气道。静脉给药白三烯C_4显著降低气管和肺外支气管的PHI样免疫反应性,同时显著增加动态呼吸阻力。少
英文摘要
(1) A high titer of peptide histidine isoleucine (PHI) antiserum which did not react with vasoactive intestinal peptide (VIP) was obtained from a rabbit immunized with rat PHI and rat PHI radioimmunoassay was established with this antiserum. Tracheas, extrapulmonary bronchi and lungs were dissected from rats sacrificed by microwave irradiation. They were homoginized with 0.5 N acetic acid and centrifuged. Lyophilized supernates were used as samples for the radioimmunoassay. PHI immunoreactivity occurred more in the central airways than in the peripheral ones. VIP immunoreactivity in rat respiratory tracts, assayed simultaneously by radioimmunoassay using commercialized VIPantiserum, was as strong as that of PHI, suggesting that PHI and VIP may be produced from the same precursor at the ratio of 1:1 in rat respiratory tracts.(2) Intravenous administration of VIP or PHI reduced dynamic respiratory resistance; however, the effect was significantly less than that of isoprenaline. VIP and P … More HI inhibited the increase in dynamic respiratory resistance by intravenous administration of histamine in a dose-dependent manner, suggesting that VIP and PHI may be involved in the pathogenesis of airway hyperresponsiveness through inhibiting the effect of mediator release on the airway.(3) VIP inhibited superoxide anion production in a dose- dependent manner by the activated peripheral blood neutrophils, mononuclear cells and also by the human monoblast cell line U937, the capacity of which for superoxide anion formation was induced by the pretreatment of interferon-gamma. 3x10^<-6> M VIP also inhibited superoxide anion generation by the activated peripheral blood eosinophils and alveolar macrophages obtained by bronchoalveolar lavage, suggesting VIP may serve as an endogenous modulator of inflammatory reactions in the respiratory tract.(4) A high titer of PHI antiserum which did not react with VIP was obtained from a rabbit immunized with rat PHI and PHI like immunoreactivity in the respiratory tract from guinea pigs was measured by radioimmunoassay. Tracheas, extrapulmonary bronchi and lungs were dissected and treated by microwave irradiation. They were homogenized with 0.5 N acetic acid and centrifuged. Lyophilized supernates were used as samples for the radioimmunoassay. PHI like immunoreactivity was present more in the central airways than in the peripheral ones. Intravenous administration of leukotriene C_4 reduced significantly PHI like immunoreactivity in the tracheas and the extrapulmonary bronchi in parallel with the significant increase of dynamic respiratory resistance. Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ishizuka T., Kurosawa M.: "Measurement of VIP immunoreactivity in the respiratory tract from guinea pigs-basic investigation about VIP extraction procedures. Jpn.J.Inflammation" 10(5). 379-382 (1990)
Ishizuka T.、Kurosawa M.:“豚鼠呼吸道 VIP 免疫反应性的测量 - VIP 提取程序的基础研究。Jpn.J.Inflammation”10(5)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishizuka T., Kurosawa M.: "Measurement of VIP immunoreactivity. Clinical Immunology" 22(Suppl.15). 114-120 (1990)
Ishizuka T.、Kurosawa M.:“VIP 免疫反应性的测量。临床免疫学”22(Suppl.15)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
青木 栄: "モルモット気道収縮反応に対するvasoactive intestinal peptide(VIP)とpeptide histidine isoleucine(PHI)の抑制効果に関する基礎的検討" 日本胸部疾患学会雑誌.
Sakae Aoki:“血管活性肠肽(VIP)和肽组氨酸异亮氨酸(PHI)对豚鼠气道收缩反应的抑制作用的基础研究”日本胸部疾病学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aoki S., Kurosawa M., Ishizuka T., Mori M.: "Inhibitory effect of vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI) on bronchoconstriction in guinea pigs. Jpn.J.Thoracic Diseases" 30(11). 1946-1950 (1992)
Aoki S.、Kurosawa M.、Ishizuka T.、Mori M.:“血管活性肠肽(VIP)和肽组氨酸异亮氨酸(PHI)对豚鼠支气管收缩的抑制作用。Jpn.J.胸部疾病”30(11)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Motohiro Kurosawa: "Neuropeptides in the respiratory tract" Drug News and Perspective. 3. 79-84 (1990)
Motohiro Kurosawa:“呼吸道中的神经肽”药物新闻与展望。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Role of mast cells in allergic inflammation in the skin
-
批准号:07670930
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:KUROSAWA Motohiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
VIP+n模式下镉污染水稻土施硫对油菜镉积累的影响及其机制研究
-
批准号:2026JJ80524
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘志祥
-
依托单位:
“近眼三针”调控视网膜VIP-VIPR2信号通路防控近视作用机制的研究
-
批准号:82560960
-
项目类别:地区科学基金项目
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:颉瑞萍
-
依托单位:
杀虫蛋白Vip3Aa结构域IV-V的靶蛋白鉴定及理性设计研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
SfMyb调控下游靶标基因介导草地贪夜蛾
Vip3Aa抗性的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:靳明辉
-
依托单位:
基 于 “ 六 腑 以 降 为 顺 ”探 讨 白 术 七 物 颗 粒 调 控
ACH/VIP/AQP3/CFTR 信号通路治疗 STC 机制研究
-
批准号:2024JJ5311
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:鲁海燕
-
依托单位:
拟南芥热激钙信号促进VIP3入核调节染色质开放和基因表达机制研究
-
批准号:32470285
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:白蛟腾
-
依托单位:
草地贪夜蛾Vip3A抗性关键基因的鉴定及功能解析
-
批准号:32472555
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:靳明辉
-
依托单位:
杀虫蛋白Vip3Aa在草地贪夜蛾肠道中的受体鉴定及其相互作用机制研究
-
批准号:32372615
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:姜昆
-
依托单位:
副交感神经肽VIP通过转录因子LITAF调控糖尿病睑板腺功能的作用及机制研究
-
批准号:82301179
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王慧凤
-
依托单位:
VIP介导的TRPV1+感觉神经通过调控免疫微环境促进乳腺癌进展的研究
-
批准号:82372866
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:周娇娇
-
依托单位: